First Time Loading...

Cegedim SA
PAR:CGM

Watchlist Manager
Cegedim SA Logo
Cegedim SA
PAR:CGM
Watchlist
Price: 14.55 EUR 0.34%
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one CGM stock under the Base Case scenario is 48.93 EUR. Compared to the current market price of 14.55 EUR, Cegedim SA is Undervalued by 70%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CGM Relative Value
Base Case
48.93 EUR
Undervaluation 70%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.3
P/S
P/S
Price to Sales
0.3
vs History
95
vs Industry
84
Median 3Y
0.5
Median 5Y
0.6
Industry
2.4
Forward
0.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
28
Median 3Y
19.2
Median 5Y
16.8
Industry
23.2
Forward
13.1
More Details
2.1
P/OCF
P/OCF
Price to OCF
2.1
vs History
95
vs Industry
52
Median 3Y
3
Median 5Y
3.2
Industry
15.5
More Details
30.9
P/FCFE
P/FCFE
Price to FCFE
30.9
vs History
9
vs Industry
19
Median 3Y
24.1
Median 5Y
15
Industry
23.5
More Details
0.7
P/B
P/B
Price to Book Value
0.7
vs History
92
vs Industry
71
Median 3Y
1
Median 5Y
1.5
Industry
2.2
More Details
0.7
EV/S
EV/S
Enterprise Value to Sales
0.7
vs History
95
vs Industry
75
Median 3Y
0.9
Median 5Y
1
Industry
2.5
Forward
0.7
More Details
3.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.6
vs History
90
vs Industry
55
Median 3Y
4.5
Median 5Y
4.7
Industry
5.2
More Details
4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
4
vs History
80
vs Industry
48
Median 3Y
4.7
Median 5Y
4.7
Industry
12.5
Forward
3.7
More Details
20.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
20.1
vs History
14
vs Industry
24
Median 3Y
15.7
Median 5Y
15.1
Industry
17.2
Forward
11.3
More Details
4.3
EV/OCF
EV/OCF
Enterprise Value to OCF
4.3
vs History
88
vs Industry
49
Median 3Y
5.1
Median 5Y
5.5
Industry
15.1
More Details
18.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
18.8
vs History
33
vs Industry
26
Median 3Y
17.3
Median 5Y
17.3
Industry
19.7
More Details
0.5
EV/IC
EV/IC
Enterprise Value to IC
0.5
vs History
95
vs Industry
76
Median 3Y
0.6
Median 5Y
0.7
Industry
2
More Details

Multiples Across Competitors

CGM Competitors Multiples
Cegedim SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Cegedim SA
PAR:CGM
197.6m EUR 0.3 -27.4 4 20.1
US
Veeva Systems Inc
NYSE:VEEV
32.5B USD 13.7 61.8 61.6 66.3
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
AU
Pro Medicus Ltd
ASX:PME
11.9B AUD 81.1 170.1 117 117
US
Inspire Medical Systems Inc
NYSE:INSP
7.4B USD 11.9 -351 -186.1 -173
JP
M3 Inc
TSE:2413
1.1T JPY 4.8 24.1 12.5 14.1
US
Doximity Inc
NYSE:DOCS
4.5B USD 9.7 32.9 22 23.5
SE
Sectra AB
STO:SECT B
42B SEK 25.6 98.9 -65.1 -65.1
US
Evolent Health Inc
NYSE:EVH
3.1B USD 1.6 -21.9 25.9 275.5
US
Certara Inc
NASDAQ:CERT
2.8B USD 7.9 -50.9 46.1 461.9
P/E Multiple
Earnings Growth
FR
Cegedim SA
PAR:CGM
Average P/E: 72.5
Negative Multiple: -27.4
67%
US
Veeva Systems Inc
NYSE:VEEV
61.8
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
170.1
119%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -351 N/A
JP
M3 Inc
TSE:2413
24.1
26%
US
Doximity Inc
NYSE:DOCS
32.9
79%
SE
Sectra AB
STO:SECT B
98.9
56%
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -21.9 N/A
US
Certara Inc
NASDAQ:CERT
Negative Multiple: -50.9 N/A
EV/EBITDA Multiple
EBITDA Growth
FR
Cegedim SA
PAR:CGM
Average EV/EBITDA: 36.1
4
31%
US
Veeva Systems Inc
NYSE:VEEV
61.6
221%
US
Cerner Corp
NASDAQ:CERN
19.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
16.5
N/A
AU
Pro Medicus Ltd
ASX:PME
117
124%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -186.1 N/A
JP
M3 Inc
TSE:2413
12.5
24%
US
Doximity Inc
NYSE:DOCS
22
103%
SE
Sectra AB
STO:SECT B
Negative Multiple: -65.1 N/A
US
Evolent Health Inc
NYSE:EVH
25.9
194%
US
Certara Inc
NASDAQ:CERT
46.1
143%
EV/EBIT Multiple
EBIT Growth
FR
Cegedim SA
PAR:CGM
Average EV/EBIT: 125.4
20.1
206%
US
Veeva Systems Inc
NYSE:VEEV
66.3
238%
US
Cerner Corp
NASDAQ:CERN
38.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
111.6
N/A
AU
Pro Medicus Ltd
ASX:PME
117
110%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -173 N/A
JP
M3 Inc
TSE:2413
14.1
N/A
US
Doximity Inc
NYSE:DOCS
23.5
116%
SE
Sectra AB
STO:SECT B
Negative Multiple: -65.1 N/A
US
Evolent Health Inc
NYSE:EVH
275.5
2 086%
US
Certara Inc
NASDAQ:CERT
461.9
2 181%

See Also

Summary
CGM intrinsic value, competitors valuation, and company profile.
DCF Valuation
CGM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CGM stock valuation using valuation multiples.
Wall Street Estimates
CGM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CGM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.